The Patent Finder
US

Liquid Degas System

US 8,152,904 In force
OverviewAssignmentsSources & methods

Also listed on Liposonix, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Collateral for a security interest recorded Jun 13, 2025 (JPMorgan Chase Bank, N.A.).

Term ends Oct 8, 2030 · High confidence

Filed Jun 4, 2010 as application 12/794,653 · Granted Apr 10, 2012
Base term plus 126 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2010 2030
Clock starts
Jun 4, 2010
Term ends
Oct 8, 2030
Granted
Apr 10, 2012
base term patent term adjustment fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
126
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.

This patent's term runs 126 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 4, 2010, when this application, 12/794,653, was filedJun 4, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+126 days, USPTO patent term adjustment recordOct 8, 2030High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events3 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 8, 2030High confidence

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 15, 2010
Reel 24540, frame 953
Slobodzian, Jonathan K.; Wing, Gregory T.Medicis Technologies CorporationAssignment of Assignor's Interest
Jan 25, 2012
Reel 27595, frame 307
Medicis Technologies CorporationLiposonix, Inc.Change of Name
Apr 3, 2013
Reel 30147, frame 642
Liposonix, Inc.Silicon Valley BankSecurity Agreement
Apr 18, 2013
Reel 30249, frame 268
Liposonix, Inc.Silicon Valley BankSecurity Interest - Mezzanine Loan
Nov 19, 2013
Reel 31674, frame 454
Liposonix, Inc.Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Liposonix, Inc.Capital Royalty Partners II L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Liposonix, Inc.Capital Royalty Partners II - Parallel Fund "a" L.P.Short-Form Patent Security Agreement
Nov 19, 2013
reel/frame not recorded
Liposonix, Inc.Parallel Investment Opportunities Partners II L.P.Short-Form Patent Security Agreement
Jan 24, 2014
Reel 32126, frame 370
Capital Royalty Partners II L.P.; Capital Royalty Partners II - Parallel Fund "a" L.P.; Parallel Investment Opportunities Partners II L.P.Liposonix, Inc.Release of Security Interest in Patents
Jan 24, 2014
Reel 32126, frame 531
Silicon Valley BankLiposonix, Inc.Release of Security Interest in Patents
Mar 11, 2019
Reel 48556, frame 758
Bausch Health Americas, Inc.; Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Interest
May 13, 2021
Reel 56227, frame 174
Aesthera; Liposonix, Inc.Solta Medical, Inc.Merger
Jun 8, 2021
Reel 56811, frame 814
Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Interest
Feb 10, 2022
Reel 59121, frame 1
Bausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.The Bank of New York MellonSecurity Agreement
Jun 13, 2022
Reel 60346, frame 705
Bausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland LimitedThe Bank of New York MellonSecurity Interest
Oct 4, 2022
Reel 61595, frame 66
Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Agreement (First Lien)
Oct 5, 2022
Reel 61606, frame 468
Bausch Health US, LLC; Bausch Health Americas, Inc.; Medicis Pharmaceutical Corporation; Orapharma, Inc.; Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Solta Medical, Inc.The Bank of New York Mellon, as Notes Collateral AgentSecurity Agreement (Second Lien)
Jun 13, 2025
Reel 71564, frame 463
Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc.The Bank of New York MellonU.S. Patent Security Agreement
Jun 13, 2025
Reel 71566, frame 200
Medicis Pharmaceutical Corporation; Orapharma, Inc.; Bausch Health US, LLC (F/K/A Valeant Pharmaceuticals North America LLC); Precision Dermatology, Inc.; Salix Pharmaceuticals, Inc.; Santarus, Inc.; Bausch Health Americas, Inc.; Solta Medical, Inc.Jpmorgan Chase Bank, N.a.U.S. Patent Security Agreement
Nov 20, 2025
Reel 73654, frame 242
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb Incorporated; Bausch Health US, LLC; Solta Medical, Inc.; Medicis Pharmaceutical Corporation; Salix Pharmaceuticals, Inc.; Salix Pharmaceuticals, Ltd.; Santarus, Inc.; Orapharma, Inc.; Precision Dermatology, Inc.; Bausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
Reel 73654, frame 300
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Companies Inc.; Bausch Health, Canada Inc.; Bausch Health Ireland Limited; Solta Medical Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Americas, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch & Lomb IncorporatedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health US, LLCRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentMedicis Pharmaceutical CorporationRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSalix Pharmaceuticals, Ltd.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSantarus, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentOrapharma, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentPrecision Dermatology, Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Companies Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health, Canada Inc.Release of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentBausch Health Ireland LimitedRelease of Security Interest
Nov 20, 2025
reel/frame not recorded
The Bank of New York Mellon, as Notes Collateral AgentSolta Medical Ireland LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited